Eli Lilly’s Mounjaro Drug Has Big Potential. How to Play the Stock.

South Africa News News

Eli Lilly’s Mounjaro Drug Has Big Potential. How to Play the Stock.
South Africa Latest News,South Africa Headlines
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 42 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 97%

The pharmaceutical company’s stock is trading in an interesting technical pattern.

The world is politically and economically combustible, but most people probably agree on this: You can never be too thin, or too rich.

If that happens, and the world order that was established after WWII breaks, chaos will likely envelope the markets. But, even then, people will likely still agree that you can never be too rich or too thin. The caveat to all that, of course, is that widespread famine or a nuclear disaster does not emerge from the current conflicts.

With Eli Lilly’s stock at $592.33, investors could sell the November $560 put for about $10.50. If the stock is above the strike price at expiration, investors can keep the put premium. The key difference between now and then is that the macro-market picture is dramatically different. So, anyone who considers the Eli Lilly trade is ultimately expressing a view that the obesity drug thesis is so robust that it can withstand whatever struggles emerge in the broad market.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

MarketWatch /  🏆 3. in US

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

What to Know Before Taking Obesity Drugs While on Birth ControlWhat to Know Before Taking Obesity Drugs While on Birth ControlGLP-1 receptor drugs, like Mounjaro, may hinder the effectiveness of oral contraceptives. It's recommended that people taking Mounjaro switch to a non-oral birth control method, or add a barrier method of contraception in the timeframe around a dose of the GLP-1 drug.
Read more »

Eli Lilly Is Waiting for Obesity-Drug Approval. How Much It Could Be Worth.Eli Lilly Is Waiting for Obesity-Drug Approval. How Much It Could Be Worth.Eli Lilly’s diabetes drug Mounjaro is expected to be approved to treat obesity in the near future. It could drive sales for more than a decade.
Read more »

Eli Lilly Is Waiting for Obesity-Drug Approval. The Stock Is a Winner Now and Later.Eli Lilly Is Waiting for Obesity-Drug Approval. The Stock Is a Winner Now and Later.Eli Lilly’s diabetes drug Mounjaro is expected to be approved to treat obesity in the near future. It could drive sales for more than a decade.
Read more »

Jets’ Aaron Rodgers gets more specific on return timeline, asks Eli Manning for helpJets’ Aaron Rodgers gets more specific on return timeline, asks Eli Manning for helpThe New York Jets and New York Giants play on Sunday but there will also be intrigue before the game.
Read more »

Jayvan Boggs, Eli Lee and thoughts on Ohio State’s big recruiting weekend: Buckeye Talk PodcastJayvan Boggs, Eli Lee and thoughts on Ohio State’s big recruiting weekend: Buckeye Talk PodcastStephen Means and Andrew Gillis discuss Ohio State recruiting.
Read more »

The Legend of 'Thanksgiving' Comes to Life in New FeaturettesThe Legend of 'Thanksgiving' Comes to Life in New FeaturettesTwo new featurettes break down the making of Eli Roth’s upcoming slasher film, Thanksgiving.
Read more »



Render Time: 2025-02-25 20:13:25